| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |